Ca. Stiller et al., NEUROFIBROMATOSIS AND CHILDHOOD LEUKAEMIA LYMPHOMA - A POPULATION-BASED UKCCSG STUDY/, British Journal of Cancer, 70(5), 1994, pp. 969-972
There is a well-known raised risk of leukaemia in children with neurof
ibromatosis type 1 (NF-1). We carried out the first detailed populatio
n-based study of leukaemia and non-Hodgkin lymphoma (NHL) associated w
ith NF-1 in order to estimate the risk and elucidate the relationship
between these conditions. Over the 17 year study period there were fiv
e cases of chronic myelomonocytic leukaemia (CMML) in patients with NF
-1 (relative risk 221; 95% CI 71-514), 12 cases of acute lymphoblastic
leukaemia (ALL) (relative risk 5.4; 95% CI 2.8-9.4) and five cases of
NHL (relative risk 10.0; 95% CI 3.3-23.4). Marrow cytogenetics could
be reviewed for seven patients. Specific abnormalities found were mono
somy 21 in a child with CMML and 7p+, 17p- in a child with ALL. No abn
ormalities were reported of 17q, which includes the NF1 gene. CMML occ
urred predominantly in boys, who also had a family history of NF-1. AL
L and NHL were more often found in children with no previous family hi
story.